col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


350 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―Jun―20 Drivers of adaptive evolution during chronic SARS-CoV-2 infections Sheri Harari, Maayan Tahor, Natalie Rutsinsky, Suzy Meijer, Danielle Miller, Oryan Henig, et al. (+6)
2 [GO] 2022―Jun―16 A randomized controlled trial to test financial incentives for COVID-19 vaccination in Ghana Raymond Duch, Edward Asiedu, Ryota Nakamura, Thomas Rouyard, Carlos Yevenes, Laurence Roope, et al. (+2)
3 [GO] 2022―Jun―16 Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance Lirong Cao, Jingzhi Lou, See Yeung Chan, Hong Zheng, Caiqi Liu, Shi Zhao, et al. (+11)
4 [GO] 2022―Jun―13 Four areas of health innovation boosted by the pandemic Chia-Yi Hou
5 [GO] 2022―Jun―08 Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California Joseph A. Lewnard, Vennis X. Hong, Manish M. Patel, Rebecca Kahn, Marc Lipsitch, Sara Y. Tartof
6 [GO] 2022―May―31 A US clinical trial network is needed for the next pandemic Rieko Yajima, Alexander F. More, Cynthia Garvan, Corina Harper, Kevin V. Grimes
7 [GO] 2022―May―30 An early warning system for emerging SARS-CoV-2 variants Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, Nathalie Worp, Bas B. Oude Munnink, Surabhi Rathore, et al. (+55)
8 [GO] 2022―May―25 Long COVID after breakthrough SARS-CoV-2 infection Ziyad Al-Aly, Benjamin Bowe, Yan Xie
9 [GO] 2022―May―23 Effectiveness of CoronaVac in children 3 to 5 years during the SARS-CoV-2 Omicron outbreak in Chile Alejandro Jara, Eduardo A. Undurraga, José R. Zubizarreta, Cecilia González, Johanna Acevedo, Alejandra Pizarro, et al. (+11)
10 [GO] 2022―May―10 Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals Andrea Brizzi, Charles Whittaker, Luciana M. S. Servo, Iwona Hawryluk, Carlos A. Prete, William M. de Souza, et al. (+35)
11 [GO] 2022―May―10 Modeling transmission of SARS-CoV-2 Omicron in China Jun Cai, Xiaowei Deng, Juan Yang, Kaiyuan Sun, Hengcong Liu, Zhiyuan Chen, et al. (+12)
12 [GO] 2022―May―09 A web-based app to provide personalized recommendations for COVID-19 Alexander H. Thieme, Maximilian Gertler, Mirja Mittermaier, Matthias I. Gröschel, Jonathan H. Chen, Brar Piening, et al. (+4)
13 [GO] 2022―May―05 A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project Diana Molino, Christine Durier, Anne Radenne, Corinne Desaint, Jacques Ropers, Soizic Courcier, et al. (+25)
14 [GO] 2022―Apr―25 Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years Ronen Arbel, Ruslan Sergienko, Michael Friger, Alon Peretz, Tanya Beckenstein, Shlomit Yaron, et al. (+2)
15 [GO] 2022―Apr―21 Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, Lina S. Sy, Carla A. Talarico, Yun Tian, et al. (+9)
16 [GO] 2022―Apr―08 Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 Olha Puhach, Kenneth Adea, Nicolas Hulo, Pascale Sattonnet, Camille Genecand, Anne Iten, et al. (+5)
17 [GO] 2022―Apr―05 Studying severe long COVID to understand post-infectious disorders beyond COVID-19 Petter Brodin, Giorgio Casari, Liam Townsend, Cliona O’Farrelly, Ivan Tancevski, Judith Löffler-Ragg, et al. (+100)
18 [GO] 2022―Apr―05 An equitable roadmap for ending the COVID-19 pandemic Mitsuru Mukaigawara, Ines Hassan, Genevie Fernandes, Lois King, Jay Patel, Devi Sridhar
19 [GO] 2022―Mar―31 Understanding COVID-19 through human challenge models Kathryn M. Edwards, Kathleen M. Neuzil
20 [GO] 2022―Mar―31 Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults Ben Killingley, Alex J. Mann, Mariya Kalinova, Alison Boyers, Niluka Goonawardane, Jie Zhou, et al. (+25)
21 [GO] 2022―Mar―28 Diabetes risk after COVID-19 Karen O’Leary
22 [GO] 2022―Mar―23 Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, et al. (+21)
23 [GO] 2022―Mar―17 Brain pathology of COVID-19 Karen O’Leary
24 [GO] 2022―Mar―15 Russian COVID-19 vaccine in jeopardy after Ukraine invasion Paul Webster
25 [GO] 2022―Mar―14 COVID-19 and resilience of healthcare systems in ten countries Catherine Arsenault, Anna Gage, Min Kyung Kim, Neena R. Kapoor, Patricia Akweongo, Freddie Amponsah, et al. (+36)
26 [GO] 2022―Mar―14 Life-or-death decisions in a pandemic Karen O’Leary
27 [GO] 2022―Mar―14 Building a pandemic supply chain - equity over equality Vivian Yee, Simar Singh Bajaj, Fatima Cody Stanford
28 [GO] 2022―Mar―11 Africa prepares for endemic COVID-19 Paul Adepoju
29 [GO] 2022―Mar―03 Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial Laurence Chu, Keith Vrbicky, David Montefiori, Wenmei Huang, Biliana Nestorova, Ying Chang, et al. (+11)
30 [GO] 2022―Feb―24 Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India Zhanwei Du, Lin Wang, Abhishek Pandey, Wey Wen Lim, Matteo Chinazzi, Ana Pastore y. Piontti, et al. (+5)
31 [GO] 2022―Feb―21 Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, Lina S. Sy, Carla A. Talarico, Yun Tian, et al. (+9)
32 [GO] 2022―Feb―17 More autopsy studies are needed to understand the pathogenesis of severe COVID-19 Scott P. Layne, Kathie-Anne Walters, John C. Kash, Jeffery K. Taubenberger
33 [GO] 2022―Feb―17 Pandemic-related barriers to the success of women in research: a framework for action Pamela B. Davis, Emma A. Meagher, Claire Pomeroy, William L. Lowe, Arthur H. Rubenstein, Joy Y. Wu, et al. (+2)
34 [GO] 2022―Feb―17 Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 Keith Sacco, Riccardo Castagnoli, Svetlana Vakkilainen, Can Liu, Ottavia M. Delmonte, Cihan Oguz, et al. (+81)
35 [GO] 2022―Feb―07 Long-term cardiovascular outcomes of COVID-19 Yan Xie, Evan Xu, Benjamin Bowe, Ziyad Al-Aly
36 [GO] 2022―Feb―07 Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants Nicole L. Welch, Meilin Zhu, Catherine Hua, Juliane Weller, Marzieh Ezzaty Mirhashemi, Tien G. Nguyen, et al. (+44)
37 [GO] 2022―Feb―04 Author Correction: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland Sarah J. Stock, Jade Carruthers, Clara Calvert, Cheryl Denny, Jack Donaghy, Anna Goulding, et al. (+16)
38 [GO] 2022―Jan―28 Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern Paul R. Wratil, Marcel Stern, Alina Priller, Annika Willmann, Giovanni Almanzar, Emanuel Vogel, et al. (+31)
39 [GO] 2022―Jan―21 A guide to immunotherapy for COVID-19 Frank L. van de Veerdonk, Evangelos Giamarellos-Bourboulis, Peter Pickkers, Lennie Derde, Helen Leavis, Reinout van Crevel, et al. (+9)
40 [GO] 2022―Jan―20 Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination Eddy Pérez-Then, Carolina Lucas, Valter Silva Monteiro, Marija Miric, Vivian Brache, Leila Cochon, et al. (+20)
41 [GO] 2022―Jan―20 Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, Susanna S. Ng, Karl C. K. Chan, Fanny W. Ko, et al. (+11)
42 [GO] 2022―Jan―20 Clinical trial design during and beyond the pandemic: the I-SPY COVID trial Carolyn S. Calfee, Kathleen D. Liu, Adam L. Asare, Jeremy R. Beitler, Paul A. Berger, Melissa H. Coleman, et al. (+112)
43 [GO] 2022―Jan―19 Effectiveness of COVID-19 booster vaccines against covid-19 related symptoms, hospitalisation and death in England Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Ruchira Sachdeva, Charlotte Gower, et al. (+2)
44 [GO] 2022―Jan―19 An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies Laura A. VanBlargan, John M. Errico, Peter J. Halfmann, Seth J. Zost, James E. Crowe, Lisa A. Purcell, et al. (+4)
45 [GO] 2022―Jan―19 mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant Henning Gruell, Kanika Vanshylla, Pinkus Tober-Lau, David Hillus, Philipp Schommers, Clara Lehmann, et al. (+3)
46 [GO] 2022―Jan―18 Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant Yu Gao, Curtis Cai, Alba Grifoni, Thomas R. Müller, Julia Niessl, Anna Olofsson, et al. (+14)
47 [GO] 2022―Jan―17 COVID-19 has revealed a pandemic of inequality Carissa F. Etienne
48 [GO] 2022―Jan―17 Post-acute neurological consequences of COVID-19: an unequal burden LaShyra T. Nolen, Shibani S. Mukerji, Nicte I. Mejia
49 [GO] 2022―Jan―14 Effectiveness of BNT162b2 COVID-19 booster vaccine against covid-19 related symptoms and hospitalization in England Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Ruchira Sachdeva, Charlotte Gower, et al. (+2)
50 [GO] 2022―Jan―14 Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever Clare Watson
51 [GO] 2022―Jan―14 Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron Yu Gao, Curtis Cai, Alba Grifoni, Thomas R. Müller, Julia Niessl, Anna Olofsson, et al. (+14)
52 [GO] 2022―Jan―13 SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland Sarah J. Stock, Jade Carruthers, Clara Calvert, Cheryl Denny, Jack Donaghy, Anna Goulding, et al. (+16)
53 [GO] 2022―Jan―12 The French health pass holds lessons for mandatory COVID-19 vaccination Jeremy K. Ward, Fatima Gauna, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Jean-Luc Cracowski, Charles Khouri, et al. (+3)
54 [GO] 2022―Jan―12 Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Philippe Bégin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, et al. (+622)
55 [GO] 2022―Jan―12 Author Correction: The impact of school opening model on SARS-CoV-2 community incidence and mortality Zeynep Ertem, Elissa M. Schechter-Perkins, Emily Oster, Polly van den Berg, Isabella Epshtein, Nathorn Chaiyakunapruk, et al. (+5)
56 [GO] 2022―Jan―12 Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission Moritz U. G. Kraemer, Oliver G. Pybus, Christophe Fraser, Simon Cauchemez, Andrew Rambaut, Benjamin J. Cowling
57 [GO] 2022―Jan―10 Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 Michael J. Joyner, Nigel S. Paneth, Jonathon W. Senefeld, DeLisa Fairweather, Katelyn A. Bruno, R. Scott Wright, et al. (+2)
58 [GO] 2022―Jan―10 Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 Philippe Bégin, Jeannie Callum, Richard Cook, Erin Jamula, Yang Liu, Andrés Finzi, et al. (+639)
59 [GO] 2021―Dec―22 The Seattle Flu Study: when regulations hinder pandemic surveillance Michael Boeckh, Helen Y. Chu, Janet A. Englund, Christina M. Lockwood, Deborah A. Nickerson, Jay Shendure, Lea Starita
60 [GO] 2021―Dec―20 Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year Joseph L. Ward, Rachel Harwood, Clare Smith, Simon Kenny, Matthew Clark, Peter J. Davis, et al. (+9)
61 [GO] 2021―Dec―14 Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection Martina Patone, Xue W. Mei, Lahiru Handunnetthi, Sharon Dixon, Francesco Zaccardi, Manu Shankar-Hari, et al. (+8)
62 [GO] 2021―Dec―14 COVID-19 in 2022: controlling the pandemic is within our grasp Maria D. Van Kerkhove
63 [GO] 2021―Dec―14 Eight unanswered questions about the COVID-19 pandemic Mike May
64 [GO] 2021―Dec―14 COVID-19 timeline of events Paul Webster
65 [GO] 2021―Dec―13 As COVID-19 vaccines arrive in Africa, Omicron is reducing supply and increasing demand Paul Adepoju
66 [GO] 2021―Nov―29 Real-time alerting system for COVID-19 and other stress events using wearable data Arash Alavi, Gireesh K. Bogu, Meng Wang, Ekanath Srihari Rangan, Andrew W. Brooks, Qiwen Wang, et al. (+23)
67 [GO] 2021―Nov―29 Publisher Correction: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection Martina Patone, Lahiru Handunnetthi, Defne Saatci, Jiafeng Pan, Srinivasa Vittal Katikireddi, Saif Razvi, et al. (+13)
68 [GO] 2021―Nov―25 Evidence-based COVID-19 policy-making in schools Elizabeth A. Stuart, David W. Dowdy
69 [GO] 2021―Nov―15 Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19 Sarthak Sinha, Nicole L. Rosin, Rohit Arora, Elodie Labit, Arzina Jaffer, Leslie Cao, et al. (+10)
70 [GO] 2021―Nov―11 Boosting immunity to COVID-19 vaccines Jennifer A. Juno, Adam K. Wheatley
71 [GO] 2021―Nov―11 Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year Clare Smith, David Odd, Rachel Harwood, Joseph Ward, Mike Linney, Matthew Clark, et al. (+9)
72 [GO] 2021―Nov―08 Monitoring key epidemiological parameters of SARS-CoV-2 transmission Moritz U. G. Kraemer, Oliver G. Pybus, Christophe Fraser, Simon Cauchemez, Andrew Rambaut, Benjamin J. Cowling
73 [GO] 2021―Nov―02 BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al Khatib, et al. (+18)
74 [GO] 2021―Nov―02 Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, et al. (+4)
75 [GO] 2021―Oct―28 What regulators must learn from COVID-19 Peter Marks
76 [GO] 2021―Oct―27 No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020 Kentaro Fukumoto, Charles T. McClean, Kuninori Nakagawa
77 [GO] 2021―Oct―27 The impact of school opening model on SARS-CoV-2 community incidence and mortality Zeynep Ertem, Elissa M. Schechter-Perkins, Emily Oster, Polly van den Berg, Isabella Epshtein, Nathorn Chaiyakunapruk, et al. (+5)
78 [GO] 2021―Oct―25 Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection Martina Patone, Lahiru Handunnetthi, Defne Saatci, Jiafeng Pan, Srinivasa Vittal Katikireddi, Saif Razvi, et al. (+13)
79 [GO] 2021―Oct―14 Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Karina-Doris Vihta, et al. (+12)
80 [GO] 2021―Oct―10 Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Evdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, Simeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, et al. (+58)
81 [GO] 2021―Oct―05 Author Correction: The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology Bas B. Oude Munnink, Nathalie Worp, David F. Nieuwenhuijse, Reina S. Sikkema, Bart Haagmans, Ron A. M. Fouchier, Marion Koopmans
82 [GO] 2021―Oct―04 COVID-19 vaccination gives hope to eradicate polio Mohammad Ali, Jafar Khan, Nisar Ahmad, Haji Khan, Arshad Iqbal, Muhammad Rizwan, et al. (+2)
83 [GO] 2021―Sep―29 Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection Shuo Feng, Daniel J. Phillips, Thomas White, Homesh Sayal, Parvinder K. Aley, Sagida Bibi, et al. (+92)
84 [GO] 2021―Sep―22 Caution before fractionating COVID-19 vaccines Annelies Wilder-Smith, Shalini Desai, Alejandro Cravioto, Hanna Nohynek, Joachim Hombach
85 [GO] 2021―Sep―15 Federated learning for predicting clinical outcomes in patients with COVID-19 Ittai Dayan, Holger R. Roth, Aoxiao Zhong, Ahmed Harouni, Amilcare Gentili, Anas Z. Abidin, et al. (+93)
86 [GO] 2021―Sep―15 Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis Angela Choi, Matthew Koch, Kai Wu, Laurence Chu, LingZhi Ma, Anna Hill, et al. (+16)
87 [GO] 2021―Sep―14 How patient data underpin COVID-19 research Marion Renault
88 [GO] 2021―Sep―14 Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, Rishi R. Goel, Divij Mathew, Kerry Lenzi, et al. (+22)
89 [GO] 2021―Sep―13 A government-led effort to identify correlates of protection for COVID-19 vaccines Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, Andrew W. Li, Najaf A. Shah, Christopher R. Houchens
90 [GO] 2021―Sep―13 Can space-based technologies help manage and prevent pandemics? Farhan M. Asrar, David Saint-Jacques, Helena J. Chapman, Dave Williams, Shirish Ravan, Ross Upshur, Jonathan B. Clark
91 [GO] 2021―Sep―09 Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Philippe Bégin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, et al. (+621)
92 [GO] 2021―Sep―09 The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology Bas B. Oude Munnink, Nathalie Worp, David F. Nieuwenhuijse, Reina S. Sikkema, Bart Haagmans, Ron A. M. Fouchier, Marion Koopmans
93 [GO] 2021―Sep―07 Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy Noa Dagan, Noam Barda, Tal Biron-Shental, Maya Makov-Assif, Calanit Key, Isaac S. Kohane, et al. (+5)
94 [GO] 2021―Sep―06 Balancing incentives and disincentives for vaccination in a pandemic Julian Savulescu, Jonathan Pugh, Dominic Wilkinson
95 [GO] 2021―Sep―03 Calming the cytokine storm in COVID-19 Randy Q. Cron, Roberto Caricchio, W. Winn Chatham
96 [GO] 2021―Sep―03 Predictors of COVID-19 epidemics in countries of the World Health Organization African Region Feifei Zhang, Humphrey Karamagi, Ngoy Nsenga, Miriam Nanyunja, Miriam Karinja, Seth Amanfo, et al. (+15)
97 [GO] 2021―Sep―03 Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Evdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, Simeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, et al. (+58)
98 [GO] 2021―Aug―31 COVID-19 boosters in rich nations will delay vaccines for all Zain Chagla, Madhukar Pai
99 [GO] 2021―Aug―23 Lessons on COVID-19 from Indigenous and remote communities of the Arctic Andrey N. Petrov, Mark Welford, Nikolay Golosov, John DeGroote, Michele Devlin, Tatiana Degai, Alexander Savelyev
100 [GO] 2021―Aug―19 Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial Emily Breza, Fatima Cody Stanford, Marcella Alsan, Burak Alsan, Abhijit Banerjee, Arun G. Chandrasekhar, et al. (+15)
101 [GO] 2021―Aug―16 Southeast Asia is an emerging hotspot for COVID-19 Thanat Chookajorn, Theerarat Kochakarn, Chaiwat Wilasang, Namfon Kotanan, Charin Modchang
102 [GO] 2021―Jul―26 A ‘mix and match’ approach to SARS-CoV-2 vaccination Meagan E. Deming, Kirsten E. Lyke
103 [GO] 2021―Jul―26 Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination Tina Schmidt, Verena Klemis, David Schub, Janine Mihm, Franziska Hielscher, Stefanie Marx, et al. (+9)
104 [GO] 2021―Jul―16 COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries Julio S. Solís Arce, Shana S. Warren, Niccolò F. Meriggi, Alexandra Scacco, Nina McMurry, Maarten Voors, et al. (+68)
105 [GO] 2021―Jul―16 Understanding COVID-19 vaccine hesitancy Shingai Machingaidze, Charles Shey Wiysonge
106 [GO] 2021―Jul―15 Another COVID-19 vaccine to boost rollout Karen O’Leary
107 [GO] 2021―Jul―14 Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination Joana Barros-Martins, Swantje I. Hammerschmidt, Anne Cossmann, Ivan Odak, Metodi V. Stankov, Gema Morillas Ramos, et al. (+19)
108 [GO] 2021―Jul―12 A French cohort for assessing COVID-19 vaccine responses in specific populations Paul Loubet, Linda Wittkop, Eric Tartour, Beatrice Parfait, Benoit Barrou, Jean-Yves Blay, et al. (+15)
109 [GO] 2021―Jul―09 mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al Khatib, Patrick Tang, Mohammad R. Hasan, et al. (+18)
110 [GO] 2021―Jul―09 A human three-dimensional neural-perivascular ‘assembloid’ promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology Lu Wang, David Sievert, Alex E. Clark, Sangmoon Lee, Hannah Federman, Benjamin D. Gastfriend, et al. (+4)
111 [GO] 2021―Jul―08 Engineered face masks detect COVID-19 Karen O’Leary
112 [GO] 2021―Jul―08 A correlate of protection for SARS-CoV-2 vaccines is urgently needed Florian Krammer
113 [GO] 2021―Jul―05 Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality Benjamin J. Cowling, Wey Wen Lim, Sarah Cobey
114 [GO] 2021―Jul―05 Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians C. S. Pramesh, Giridhara R. Babu, Joyeeta Basu, Indu Bhushan, Christopher M. Booth, Girish Chinnaswamy, et al. (+12)
115 [GO] 2021―Jun―29 Reduction in life expectancy in Brazil after COVID-19 Marcia C. Castro, Susie Gurzenda, Cassio M. Turra, Sun Kim, Theresa Andrasfay, Noreen Goldman
116 [GO] 2021―Jun―28 Emergence of measles during the COVID-19 pandemic threatens Pakistan’s children and the wider region Muhammad Suleman Rana, Muhammad Masroor Alam, Aamer Ikram, Muhammad Salman, Mohammad Osama Mere, Muhammad Usman, et al. (+3)
117 [GO] 2021―Jun―28 Asian healthcare workers in the COVID-19 pandemic: a long road to recovery Jo-Hsuan Wu
118 [GO] 2021―Jun―28 Building a pandemic-proof vaccine Karen O’Leary
119 [GO] 2021―Jun―21 Brazil needs a coordinated and cooperative approach to tackle COVID-19 Lorena G. Barberia, Silvia Figueiredo Costa, Ester C. Sabino
120 [GO] 2021―Jun―21 Has SARS-CoV-2 reached peak fitness? Roberto Burioni, Eric J. Topol
121 [GO] 2021―Jun―18 Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19 Carolina Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Julio Silva, et al. (+99)
122 [GO] 2021―Jun―14 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals Talia Kustin, Noam Harel, Uriah Finkel, Shay Perchik, Sheri Harari, Maayan Tahor, et al. (+23)
123 [GO] 2021―Jun―10 Strengthened health systems are needed to tackle COVID-19 in Africa Moses Alobo
124 [GO] 2021―Jun―10 Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals Oren Milman, Idan Yelin, Noga Aharony, Rachel Katz, Esma Herzel, Amir Ben-Tov, et al. (+5)
125 [GO] 2021―Jun―09 First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland C. R. Simpson, T. Shi, E. Vasileiou, S. V. Katikireddi, S. Kerr, E. Moore, et al. (+24)
126 [GO] 2021―Jun―09 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Owen Gethings, Karina-Doris Vihta, et al. (+14)
127 [GO] 2021―Jun―09 COVID-19 vaccination and immune thrombocytopenia Allyson M. Pishko, James B. Bussel, Douglas B. Cines
128 [GO] 2021―Jun―03 High COVID-19 death toll in Africa Karen O’Leary
129 [GO] 2021―May―31 After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases Mike May
130 [GO] 2021―May―27 SARS-CoV-2 variants of concern are emerging in India Jasdeep Singh, Syed Asad Rahman, Nasreen Z. Ehtesham, Subhash Hira, Seyed E. Hasnain
131 [GO] 2021―May―25 COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence Felipe Gomes Naveca, Valdinete Nascimento, Victor Costa de Souza, André de Lima Corado, Fernanda Nascimento, George Silva, et al. (+23)
132 [GO] 2021―May―24 To curb COVID-19, global health must go local
133 [GO] 2021―May―24 The world needs an intergovernmental panel on pandemic risk Ben Oppenheim, Kaysie Brown, Ron Waldman
134 [GO] 2021―May―21 Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie J. Ewer, Jordan R. Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter, et al. (+40)
135 [GO] 2021―May―20 CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Erin M. Bange, Nicholas A. Han, Paul Wileyto, Justin Y. Kim, Sigrid Gouma, James Robinson, et al. (+54)
136 [GO] 2021―May―18 Equitable allocation of COVID-19 vaccines in the United States Harald Schmidt, Rebecca Weintraub, Michelle A. Williams, Kate Miller, Alison Buttenheim, Emily Sadecki, et al. (+5)
137 [GO] 2021―May―18 Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 Brian J. Ward, Philipe Gobeil, Annie Séguin, Judith Atkins, Iohann Boulay, Pierre-Yves Charbonneau, et al. (+13)
138 [GO] 2021―May―17 Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries Victoria Haldane, Chuan De Foo, Salma M. Abdalla, Anne-Sophie Jung, Melisa Tan, Shishi Wu, et al. (+14)
139 [GO] 2021―May―17 Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection David S. Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E. Schlub, Adam K. Wheatley, Jennifer A. Juno, et al. (+4)
140 [GO] 2021―May―13 Tocilizumab for the treatment of severe COVID-19 Karen O’Leary
141 [GO] 2021―May―10 SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies Emanuele Andreano, Rino Rappuoli
142 [GO] 2021―May―10 Sustained behavior change is key to preventing and tackling future pandemics Susan Michie, Robert West
143 [GO] 2021―May―06 Overcoming Brazil’s monumental COVID-19 failure: an urgent call to action Pedro C. Hallal, Cesar G. Victora
144 [GO] 2021―May―06 Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Jordan R. Barrett, Sandra Belij-Rammerstorfer, Christina Dold, Katie J. Ewer, Pedro M. Folegatti, Ciaran Gilbride, et al. (+48)
145 [GO] 2021―May―05 Delayed production of neutralizing antibodies correlates with fatal COVID-19 Carolina Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Julio Silva, et al. (+31)
146 [GO] 2021―May―04 Author Correction: What do journalists say about covering science during the COVID-19 pandemic? Anita Makri
147 [GO] 2021―May―04 Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff
148 [GO] 2021―Apr―29 COVID-19 vaccine and blood clotting
149 [GO] 2021―Apr―26 Being fair to participants in placebo-controlled COVID-19 vaccine trials Rafael Dal-Ré, Walter Orenstein, Arthur L. Caplan
150 [GO] 2021―Apr―22 Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study Jingxin Li, Aimin Hui, Xiang Zhang, Yumei Yang, Rong Tang, Huayue Ye, et al. (+16)
151 [GO] 2021―Apr―20 Single-cell multi-omics analysis of the immune response in COVID-19 Emily Stephenson, Gary Reynolds, Rachel A. Botting, Fernando J. Calero-Nieto, Michael D. Morgan, Zewen Kelvin Tuong, et al. (+62)
152 [GO] 2021―Apr―19 Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations Monette Zard, Ling San Lau, Diana M. Bowser, Fouad M. Fouad, Diego I. Lucumí, Goleen Samari, et al. (+7)
153 [GO] 2021―Apr―19 COVID-19 dynamics after a national immunization program in Israel Hagai Rossman, Smadar Shilo, Tomer Meir, Malka Gorfine, Uri Shalit, Eran Segal
154 [GO] 2021―Apr―16 Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy Giulia Giordano, Marta Colaneri, Alessandro Di Filippo, Franco Blanchini, Paolo Bolzern, Giuseppe De Nicolao, et al. (+3)
155 [GO] 2021―Apr―15 Comprehensive large-scale nucleic acid-testing strategies support China’s sustained containment of COVID-19 Zhongjie Li, Fengfeng Liu, Jinzhao Cui, Zhibin Peng, Zhaorui Chang, Shengjie Lai, et al. (+4)
156 [GO] 2021―Apr―15 “I had to be with bodyguards with guns”-attacks on scientists during the pandemic Anita Makri
157 [GO] 2021―Apr―09 Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 Liam Gaziano, Claudia Giambartolomei, Alexandre C. Pereira, Anna Gaulton, Daniel C. Posner, Sonja A. Swanson, et al. (+50)
158 [GO] 2021―Apr―07 Africa needs more genome sequencing to tackle new variants of SARS-CoV-2 Akaninyene Otu, Emmanuel Agogo, Bassey Ebenso
159 [GO] 2021―Apr―05 Changing climate and the COVID-19 pandemic: more than just heads or tails Xavier Rodó, Adrià San-José, Karin Kirchgatter, Leonardo López
160 [GO] 2021―Apr―01 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 Joseph E. Ebinger, Justyna Fert-Bober, Ignat Printsev, Min Wu, Nancy Sun, John C. Prostko, et al. (+6)
161 [GO] 2021―Mar―30 Public opinion on global rollout of COVID-19 vaccines Philip M. Clarke, Laurence S. J. Roope, Peter John Loewen, Jean-Francois Bonnefon, Alessia Melegaro, Jorge Friedman, et al. (+3)
162 [GO] 2021―Mar―29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine Matan Levine-Tiefenbrun, Idan Yelin, Rachel Katz, Esma Herzel, Ziv Golan, Licita Schreiber, et al. (+8)
163 [GO] 2021―Mar―26 Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies Delphine Planas, Timothée Bruel, Ludivine Grzelak, Florence Guivel-Benhassine, Isabelle Staropoli, Françoise Porrot, et al. (+27)
164 [GO] 2021―Mar―25 SARS-CoV-2 infection of the oral cavity and saliva Ni Huang, Paola Pérez, Takafumi Kato, Yu Mikami, Kenichi Okuda, Rodney C. Gilmore, et al. (+46)
165 [GO] 2021―Mar―22 Post-acute COVID-19 syndrome Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens, et al. (+28)
166 [GO] 2021―Mar―16 Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff
167 [GO] 2021―Mar―15 Nowcasting epidemics of novel pathogens: lessons from COVID-19 Joseph T. Wu, Kathy Leung, Tommy T. Y. Lam, Michael Y. Ni, Carlos K. H. Wong, J. S. Malik Peiris, Gabriel M. Leung
168 [GO] 2021―Mar―15 COVID-19: unprecedented but expected John N. Nkengasong
169 [GO] 2021―Mar―15 Tracking the emergence of new SARS-CoV-2 variants in South Africa Anise N. Happi, Chinedu A. Ugwu, Christian T. Happi
170 [GO] 2021―Mar―15 Beyond recruitment: good participatory practice enhances the impact of research in a pandemic Barthalomew Wilson, Katharine Wright, Robert Taylor, Elizabeth Higgs
171 [GO] 2021―Mar―15 Hindsight is 2020? Lessons in global health governance one year into the pandemic Ines Hassan, Mitsuru Mukaigawara, Lois King, Genevie Fernandes, Devi Sridhar
172 [GO] 2021―Mar―15 Preparing for the next pandemic
173 [GO] 2021―Mar―15 Will this pandemic be the catalyst to finally reform humanitarian responses? Paul B. Spiegel
174 [GO] 2021―Mar―15 Art in a pandemic: a digital gallery Hannah Stower, Marianne Guennot
175 [GO] 2021―Mar―11 The battle for COVID-19 vaccines highlights the need for a new global governance mechanism Anna Mia Ekström, Camilla Berggren, Göran Tomson, Lawrence O. Gostin, Peter Friberg, Ole Petter Ottersen
176 [GO] 2021―Mar―04 Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies Rita E. Chen, Xianwen Zhang, James Brett Case, Emma S. Winkler, Yang Liu, Laura A. VanBlargan, et al. (+26)
177 [GO] 2021―Mar―02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, et al. (+13)
178 [GO] 2021―Mar―02 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics Christoph Muus, Malte D. Luecken, Gökcen Eraslan, Lisa Sikkema, Avinash Waghray, Graham Heimberg, et al. (+108)
179 [GO] 2021―Mar―01 Assessing the human immune response to SARS-CoV-2 variants Roberto Burioni, Eric J. Topol
180 [GO] 2021―Feb―25 A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity Sirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, David R. Morrison, Jonathan Afilalo, Marc Afilalo, et al. (+35)
181 [GO] 2021―Feb―17 Time to evaluate COVID-19 contact-tracing apps Vittoria Colizza, Eva Grill, Rafael Mikolajczyk, Ciro Cattuto, Adam Kucharski, Steven Riley, et al. (+7)
182 [GO] 2021―Feb―17 A dangerous measles future looms beyond the COVID-19 pandemic David N. Durrheim, Jon K. Andrus, Shahina Tabassum, Hyam Bashour, David Githanga, Günter Pfaff
183 [GO] 2021―Feb―17 COVID-19 vaccination: the VOICE for patients with cancer Astrid A. M. van der Veldt, Sjoukje F. Oosting, Anne-Marie C. Dingemans, Rudolf S. N. Fehrmann, Corine GeurtsvanKessel, Mathilde Jalving, et al. (+13)
184 [GO] 2021―Feb―17 Humoral signatures of protective and pathological SARS-CoV-2 infection in children Yannic C. Bartsch, Chuangqi Wang, Tomer Zohar, Stephanie Fischinger, Caroline Atyeo, John S. Burke, et al. (+16)
185 [GO] 2021―Feb―08 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R. Fontes-Garfias, et al. (+8)
186 [GO] 2021―Feb―06 Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+52)
187 [GO] 2021―Feb―04 COVID-19 survivors at 6 months Jennifer Sargent
188 [GO] 2021―Feb―04 COVID-19 vaccines: acting on the evidence
189 [GO] 2021―Feb―02 Sixteen novel lineages of SARS-CoV-2 in South Africa Houriiyah Tegally, Eduan Wilkinson, Richard J. Lessells, Jennifer Giandhari, Sureshnee Pillay, Nokukhanya Msomi, et al. (+25)
190 [GO] 2021―Feb―02 Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa Benjamin L. Rice, Akshaya Annapragada, Rachel E. Baker, Marjolein Bruijning, Winfred Dotse-Gborgbortsi, Keitly Mensah, et al. (+11)
191 [GO] 2021―Feb―02 Author Correction: Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries Vasilis Kontis, James E. Bennett, Theo Rashid, Robbie M. Parks, Jonathan Pearson-Stuttard, Michel Guillot, et al. (+8)
192 [GO] 2021―Jan―28 Neurological effects of COVID-19 in children Hannah Stower
193 [GO] 2021―Jan―25 Ethical considerations of COVID-19-related adjustments to clinical research Nina S. Hsu, Saskia Hendriks, Khara M. Ramos, Christine Grady
194 [GO] 2021―Jan―19 Looking beyond COVID-19 vaccine phase 3 trials Jerome H. Kim, Florian Marks, John D. Clemens
195 [GO] 2021―Jan―13 Immune determinants of COVID-19 disease presentation and severity Petter Brodin
196 [GO] 2021―Jan―13 What do journalists say about covering science during the COVID-19 pandemic? Anita Makri
197 [GO] 2021―Jan―13 On the origins of SARS-CoV-2 Angela L. Rasmussen
198 [GO] 2021―Jan―11 Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility? Tracey Weissgerber, Nico Riedel, Halil Kilicoglu, Cyril Labbé, Peter Eckmann, Gerben ter Riet, et al. (+11)
199 [GO] 2021―Jan―11 Author Correction: A global survey of potential acceptance of a COVID-19 vaccine Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, et al. (+2)
200 [GO] 2020―Dec―18 Difficult trade-offs in response to COVID-19: the case for open and inclusive decision making Ole F. Norheim, Joelle M. Abi-Rached, Liam Kofi Bright, Kristine Bærøe, Octávio L. M. Ferraz, Siri Gloppen, Alex Voorhoeve
201 [GO] 2020―Dec―17 Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Jordan R. Barrett, Sandra Belij-Rammerstorfer, Christina Dold, Katie J. Ewer, Pedro M. Folegatti, Ciaran Gilbride, et al. (+48)
202 [GO] 2020―Dec―17 T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie J. Ewer, Jordan R. Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter, et al. (+40)
203 [GO] 2020―Dec―11 Individual and community-level risk for COVID-19 mortality in the United States Jin Jin, Neha Agarwala, Prosenjit Kundu, Benjamin Harvey, Yuqi Zhang, Eliza Wallace, Nilanjan Chatterjee
204 [GO] 2020―Dec―07 COVID-19 clusters Thiago Carvalho
205 [GO] 2020―Dec―07 Interferon linked to COVID-19 severity Thiago Carvalho
206 [GO] 2020―Dec―07 COVID-19-induced Kawasaki disease Thiago Carvalho
207 [GO] 2020―Dec―07 COVID-19: what health experts could and could not predict Devi Sridhar
208 [GO] 2020―Dec―07 Extrapulmonary SARS-CoV-2 manifestations Thiago Carvalho
209 [GO] 2020―Nov―30 Toward superhuman SARS-CoV-2 immunity? Dennis R. Burton, Eric J. Topol
210 [GO] 2020―Nov―30 Effective control of SARS-CoV-2 transmission in Wanzhou, China Qiuling Shi, Yaoyue Hu, Bin Peng, Xiao-Jun Tang, Wei Wang, Kun Su, et al. (+9)
211 [GO] 2020―Nov―27 Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
212 [GO] 2020―Nov―27 Author Correction: Modeling COVID-19 scenarios for the United States
213 [GO] 2020―Nov―27 Publisher Correction: Responding to the hidden pandemic for healthcare workers: stress John H. Krystal
214 [GO] 2020―Nov―23 Will patient-centric sampling become the norm for clinical trials after COVID-19? Christopher A. James, Matthew D. Barfield, Katie F. Maass, Shefali R. Patel, Melanie D. Anderson
215 [GO] 2020―Nov―23 Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates Molly E. Gallagher, Andrew J. Sieben, Kristin N. Nelson, Alicia N. M. Kraay, Walter A. Orenstein, Ben Lopman, et al. (+2)
216 [GO] 2020―Nov―12 Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells Isabel Schulien, Janine Kemming, Valerie Oberhardt, Katharina Wild, Lea M. Seidel, Saskia Killmer, et al. (+25)
217 [GO] 2020―Oct―30 Diversifying the biomedical workforce during the COVID-19 pandemic Long H. Nguyen, Aswita Tan-McGrory, Alice Y. Oh, Esteban A. Barreto, Stephen J. Bartels, Katrina A. Armstrong, et al. (+2)
218 [GO] 2020―Oct―29 Wearable sensor data and self-reported symptoms for COVID-19 detection Giorgio Quer, Jennifer M. Radin, Matteo Gadaleta, Katie Baca-Motes, Lauren Ariniello, Edward Ramos, et al. (+3)
219 [GO] 2020―Oct―23 Modeling COVID-19 scenarios for the United States
220 [GO] 2020―Oct―22 Understanding protection from SARS-CoV-2 by studying reinfection Julie Overbaugh
221 [GO] 2020―Oct―20 A global survey of potential acceptance of a COVID-19 vaccine Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, et al. (+2)
222 [GO] 2020―Oct―20 Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands Bas B. Oude Munnink, David F. Nieuwenhuijse, Mart Stein, Áine O’Toole, Manon Haverkate, Madelief Mollers, et al. (+19)
223 [GO] 2020―Oct―16 Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France Nicolas Hoertel, Martin Blachier, Carlos Blanco, Mark Olfson, Marc Massetti, Marina Sánchez Rico, et al. (+2)
224 [GO] 2020―Oct―14 Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries Vasilis Kontis, James E. Bennett, Theo Rashid, Robbie M. Parks, Jonathan Pearson-Stuttard, Michel Guillot, et al. (+8)
225 [GO] 2020―Oct―09 COVID-19 puts the Sustainable Development Goals center stage Ole Petter Ottersen, Eivind Engebretsen
226 [GO] 2020―Oct―05 Crowding and the shape of COVID-19 epidemics Benjamin Rader, Samuel V. Scarpino, Anjalika Nande, Alison L. Hill, Ben Adlam, Robert C. Reiner, et al. (+10)
227 [GO] 2020―Sep―22 COVID-19 clinical trials: learning from exceptions in the research chaos Kari A. O. Tikkinen, Reza Malekzadeh, Martin Schlegel, Jarno Rutanen, Paul Glasziou
228 [GO] 2020―Sep―17 Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong Dillon C. Adam, Peng Wu, Jessica Y. Wong, Eric H. Y. Lau, Tim K. Tsang, Simon Cauchemez, et al. (+2)
229 [GO] 2020―Sep―15 Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study Sean T. H. Liu, Hung-Mo Lin, Ian Baine, Ania Wajnberg, Jeffrey P. Gumprecht, Farah Rahman, et al. (+24)
230 [GO] 2020―Sep―14 Seasonal coronavirus protective immunity is short-lasting Arthur W. D. Edridge, Joanna Kaczorowska, Alexis C. R. Hoste, Margreet Bakker, Michelle Klein, Katherine Loens, et al. (+10)
231 [GO] 2020―Sep―10 Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
232 [GO] 2020―Sep―10 Developing COVID-19 vaccines Hannah Stower
233 [GO] 2020―Sep―04 Controlling the COVID-19 pandemic in Brazil: a challenge of continental proportions Mayra Monteiro de Oliveira, Trevon L. Fuller, Patricia Brasil, Claudia R. Gabaglia, Karin Nielsen-Saines
234 [GO] 2020―Sep―03 Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters Lisa H. Tostanoski, Frank Wegmann, Amanda J. Martinot, Carolin Loos, Katherine McMahan, Noe B. Mercado, et al. (+38)
235 [GO] 2020―Aug―24 COVID-19 puts health research to the test in Africa Paul Adepoju
236 [GO] 2020―Aug―24 An inflammatory cytokine signature predicts COVID-19 severity and survival Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg, Bo Wang, et al. (+26)
237 [GO] 2020―Aug―24 Vaccines targeting SARS-CoV-2 tested in humans Kathryn M. Edwards
238 [GO] 2020―Aug―21 Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+50)
239 [GO] 2020―Aug―18 Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Xin Xu, Jian Sun, Sheng Nie, Huiyuan Li, Yaozhong Kong, Min Liang, et al. (+16)
240 [GO] 2020―Aug―18 Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection Michael J. Carter, Matthew Fish, Aislinn Jennings, Katie J. Doores, Paul Wellman, Jeffrey Seow, et al. (+8)
241 [GO] 2020―Aug―17 A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, et al. (+44)
242 [GO] 2020―Aug―17 Effects of disruption from COVID-19 on antimalarial strategies Rashid Ansumana, Osman Sankoh, Alimuddin Zumla
243 [GO] 2020―Aug―17 Is presymptomatic spread a major contributor to COVID-19 transmission? Mark K. Slifka, Lina Gao
244 [GO] 2020―Aug―17 Reply to: Is presymptomatic spread a major contributor to COVID-19 transmission? Eric H. Y. Lau, Gabriel M. Leung
245 [GO] 2020―Aug―07 Brazil’s policies condemn Amazonia to a second wave of COVID-19 Lucas Ferrante, Wilhelm Alexander Steinmetz, Alexandre Celestino Leite Almeida, Jeremias Leão, Ruth Camargo Vassão, Unaí Tupinambás, et al. (+2)
246 [GO] 2020―Aug―07 Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Xilong Deng, Jian Wang, Xinxin Hao, et al. (+17)
247 [GO] 2020―Aug―07 Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19 Sara Gerke, Carmel Shachar, Peter R. Chai, I. Glenn Cohen
248 [GO] 2020―Aug―07 Digital technologies in the public-health response to COVID-19 Jobie Budd, Benjamin S. Miller, Erin M. Manning, Vasileios Lampos, Mengdie Zhuang, Michael Edelstein, et al. (+11)
249 [GO] 2020―Aug―07 Using a real-world network to model localized COVID-19 control strategies Josh A. Firth, Joel Hellewell, Petra Klepac, Stephen Kissler, Adam J. Kucharski, Lewis G. Spurgin
250 [GO] 2020―Aug―07 The potential public health consequences of COVID-19 on malaria in Africa Ellie Sherrard-Smith, Alexandra B. Hogan, Arran Hamlet, Oliver J. Watson, Charlie Whittaker, Peter Winskill, et al. (+23)
251 [GO] 2020―Aug―07 Seeds of hope in COVID-19 vaccine preliminary data Hannah Stower
252 [GO] 2020―Aug―03 Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection Vijendra Ramlall, Phyllis M. Thangaraj, Cem Meydan, Jonathan Foox, Daniel Butler, Jacob Kim, et al. (+6)
253 [GO] 2020―Jul―27 Assessing the extent of SARS-CoV-2 circulation through serological studies Marion Koopmans, Bart Haagmans
254 [GO] 2020―Jul―27 Sampling the host response to SARS-CoV-2 in hospitals under siege Alexander W. Charney, Nicole W. Simons, Konstantinos Mouskas, Lauren Lepow, Esther Cheng, Jessica Le Berichel, et al. (+50)
255 [GO] 2020―Jul―16 Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands Bas B. Oude Munnink, David F. Nieuwenhuijse, Mart Stein, Áine O’Toole, Manon Haverkate, Madelief Mollers, et al. (+19)
256 [GO] 2020―Jul―15 How computational immunology changed the face of COVID-19 vaccine development Carrie Arnold
257 [GO] 2020―Jul―14 A stochastic agent-based model of the SARS-CoV-2 epidemic in France Nicolas Hoertel, Martin Blachier, Carlos Blanco, Mark Olfson, Marc Massetti, Marina Sánchez Rico, et al. (+2)
258 [GO] 2020―Jul―13 Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 Jennifer A. Juno, Hyon-Xhi Tan, Wen Shi Lee, Arnold Reynaldi, Hannah G. Kelly, Kathleen Wragg, et al. (+14)
259 [GO] 2020―Jul―10 Extrapulmonary manifestations of COVID-19 Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan, Tejasav S. Sehrawat, et al. (+23)
260 [GO] 2020―Jul―10 Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, James Brett Case, Joseph X. Reidy, Andrew Trivette, et al. (+25)
261 [GO] 2020―Jul―10 The ethics of deferred consent in times of pandemics Rieke van der Graaf, Marie-Astrid Hoogerwerf, Martine C. de Vries
262 [GO] 2020―Jul―09 Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling Rebecca J. Rockett, Alicia Arnott, Connie Lam, Rosemarie Sadsad, Verlaine Timms, Karen-Ann Gray, et al. (+18)
263 [GO] 2020―Jul―08 Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil Mariângela F. Silveira, Aluísio J. D. Barros, Bernardo L. Horta, Lúcia C. Pellanda, Gabriel D. Victora, Odir A. Dellagostin, et al. (+15)
264 [GO] 2020―Jul―02 COVID-19 Research in Brief: 30 May to 5 June, 2020 Thiago Carvalho
265 [GO] 2020―Jun―26 COVID-19 Research in Brief: December, 2019 to June, 2020 Thiago Carvalho
266 [GO] 2020―Jun―26 Publisher Correction: Building an international consortium for tracking coronavirus health status Eran Segal, Feng Zhang, Xihong Lin, Gary King, Ophir Shalem, Smadar Shilo, et al. (+47)
267 [GO] 2020―Jun―24 Determinants of COVID-19 disease severity in patients with cancer Elizabeth V. Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocio Perez-Johnston, Marilia Bernardes, et al. (+22)
268 [GO] 2020―Jun―19 COVID-19 Research in Brief: 13 June to 19 June, 2020 Thiago Carvalho
269 [GO] 2020―Jun―18 Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Quan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, Qin Li, Hai-Jun Deng, Jun Yuan, et al. (+13)
270 [GO] 2020―Jun―16 Age-dependent effects in the transmission and control of COVID-19 epidemics Nicholas G. Davies, Petra Klepac, Yang Liu, Kiesha Prem, Mark Jit, Rosalind M. Eggo
271 [GO] 2020―Jun―16 Disease and healthcare burden of COVID-19 in the United States Ian F. Miller, Alexander D. Becker, Bryan T. Grenfell, C. Jessica E. Metcalf
272 [GO] 2020―Jun―16 COVID-19 Research in Brief: 6 June to 12 June, 2020 Thiago Carvalho
273 [GO] 2020―Jun―15 Biobanks could identify medically actionable findings relevant for COVID-19 clinical care Andrew B. Stergachis, Scott T. Weiss, Robert C. Green
274 [GO] 2020―Jun―11 Keeping governments accountable: the COVID-19 Assessment Scorecard (COVID-SCORE) Jeffrey V. Lazarus, Agnes Binagwaho, Ayman A. E. El-Mohandes, Jonathan E. Fielding, Heidi J. Larson, Antoni Plasència, et al. (+2)
275 [GO] 2020―Jun―11 COVID-19 in Africa: the spread and response Marguerite Massinga Loembé, Akhona Tshangela, Stephanie J. Salyer, Jay K. Varma, Ahmed E. Ogwell Ouma, John N. Nkengasong
276 [GO] 2020―Jun―11 Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course? Bamba Gaye, Stéphanie Khoury, Crystal W. Cene, Samuel Kingue, Roland N’Guetta, Camille Lassale, et al. (+5)
277 [GO] 2020―Jun―11 Kawasaki disease in a COVID-19-struck region Hannah Stower
278 [GO] 2020―Jun―08 A single-cell atlas of the peripheral immune response in patients with severe COVID-19 Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, Jonasel Roque, Giovanny J. Martínez-Colón, Julia L. McKechnie, et al. (+9)
279 [GO] 2020―Jun―08 Preserve junior faculty in biomedical sciences during and after the pandemic Prachee Avasthi, Ushma S. Neill, Keshia M. Pollack Porter, Ashani T. Weeraratna
280 [GO] 2020―Jun―05 Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Xin Xu, Jian Sun, Sheng Nie, Huiyuan Li, Yaozhong Kong, Min Liang, et al. (+16)
281 [GO] 2020―Jun―03 Author Correction: Caring for patients with cancer in the COVID-19 era Joris van de Haar, Louisa R. Hoes, Charlotte E. Coles, Kenneth Seamon, Stefan Fröhling, Dirk Jäger, et al. (+15)
282 [GO] 2020―Jun―02 Building an international consortium for tracking coronavirus health status Eran Segal, Feng Zhang, Xihong Lin, Gary King, Ophir Shalem, Smadar Shilo, et al. (+47)
283 [GO] 2020―May―29 COVID-19 Research in Brief: 23 May to 29 May, 2020 Thiago Carvalho
284 [GO] 2020―May―26 Use of apps in the COVID-19 response and the loss of privacy protection Tanusree Sharma, Masooda Bashir
285 [GO] 2020―May―26 Mass-surveillance technologies to fight coronavirus spread: the case of Israel Moran Amit, Heli Kimhi, Tarif Bader, Jacob Chen, Elon Glassberg, Avi Benov
286 [GO] 2020―May―22 COVID-19 Research in Brief: 16 May to 22 May, 2020 Thiago Carvalho
287 [GO] 2020―May―22 Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence Vineet D. Menachery, Boyd L. Yount, Kari Debbink, Sudhakar Agnihothram, Lisa E. Gralinski, Jessica A. Plante, et al. (+9)
288 [GO] 2020―May―21 Low- and middle-income countries face up to COVID-19 Miriam Shuchman
289 [GO] 2020―May―21 Addendum: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, et al. (+3)
290 [GO] 2020―May―19 Artificial intelligence-enabled rapid diagnosis of patients with COVID-19 Xueyan Mei, Hao-Chih Lee, Kai-yue Diao, Mingqian Huang, Bin Lin, Chenyu Liu, et al. (+22)
291 [GO] 2020―May―15 15 drugs being tested to treat COVID-19 and how they would work Leah Shaffer
292 [GO] 2020―May―15 COVID-19 Research in Brief: 9 May to 15 May, 2020 Thiago Carvalho
293 [GO] 2020―May―13 Infection of bat and human intestinal organoids by SARS-CoV-2 Jie Zhou, Cun Li, Xiaojuan Liu, Man Chun Chiu, Xiaoyu Zhao, Dong Wang, et al. (+14)
294 [GO] 2020―May―12 Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 Mingfeng Liao, Yang Liu, Jing Yuan, Yanling Wen, Gang Xu, Juanjuan Zhao, et al. (+8)
295 [GO] 2020―May―12 The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak Tsegahun Manyazewal, Yimtubezinash Woldeamanuel, Henry M. Blumberg, Abebaw Fekadu, Vincent C. Marconi
296 [GO] 2020―May―12 ‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing Kamalini Ramdas, Ara Darzi, Sanjay Jain
297 [GO] 2020―May―12 A serological assay to detect SARS-CoV-2 seroconversion in humans Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, Thi H. O. Nguyen, Veronika Chromikova, Meagan McMahon, et al. (+24)
298 [GO] 2020―May―11 Real-time tracking of self-reported symptoms to predict potential COVID-19 Cristina Menni, Ana M. Valdes, Maxim B. Freidin, Carole H. Sudre, Long H. Nguyen, David A. Drew, et al. (+14)
299 [GO] 2020―May―11 Supporting the UK National Health Service during the COVID-19 crisis from an academic perspective Matthias Trost
300 [GO] 2020―May―11 COVID-19 in Padua, Italy: not just an economic and health issue Francesco Paolo Russo
301 [GO] 2020―May―11 Fast and frugal innovations in response to the COVID-19 pandemic Matthew Harris, Yasser Bhatti, Jim Buckley, Dhananjaya Sharma
302 [GO] 2020―May―08 COVID-19 Research in Brief: 2 May to 8 May, 2020 Thiago Carvalho
303 [GO] 2020―May―07 Protect against market exclusivity in the fight against COVID-19 Ellen ’t Hoen
304 [GO] 2020―May―07 Modeling shield immunity to reduce COVID-19 epidemic spread Joshua S. Weitz, Stephen J. Beckett, Ashley R. Coenen, David Demory, Marian Dominguez-Mirazo, Jonathan Dushoff, et al. (+7)
305 [GO] 2020―May―07 Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry Paul Hofman, Pascal Puchois, Patrick Brest, Hicham Lahlou, Daniel Simeon-Dubach
306 [GO] 2020―May―01 An overdose surge will compound the COVID-19 pandemic if urgent action is not taken Sarah E. Wakeman, Traci C. Green, Josiah Rich
307 [GO] 2020―May―01 COVID-19 Research in Brief: 24 April to 1 May, 2020 Thiago Carvalho
308 [GO] 2020―Apr―29 Antibody responses to SARS-CoV-2 in patients with COVID-19 Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, Gui-Cheng Wu, Kun Deng, Yao-Kai Chen, et al. (+45)
309 [GO] 2020―Apr―29 Responding to the hidden pandemic for healthcare workers: stress John H. Krystal, Robert L. McNeil
310 [GO] 2020―Apr―27 Antibody testing will enhance the power and accuracy of COVID-19-prevention trials Marc Lipsitch, Rebecca Kahn, Michael J. Mina
311 [GO] 2020―Apr―24 COVID-19 Research in Brief: 18 April to 24 April, 2020 Thiago Carvalho
312 [GO] 2020―Apr―24 The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin Ehud Chorin, Matthew Dai, Eric Shulman, Lalit Wadhwani, Roi Bar-Cohen, Chirag Barbhaiya, et al. (+7)
313 [GO] 2020―Apr―23 Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
314 [GO] 2020―Apr―23 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Waradon Sungnak, Ni Huang, Christophe Bécavin, Marijn Berg, Rachel Queen, Monika Litvinukova, et al. (+7)
315 [GO] 2020―Apr―22 Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy Giulia Giordano, Franco Blanchini, Raffaele Bruno, Patrizio Colaneri, Alessandro Di Filippo, Angela Di Matteo, Marta Colaneri
316 [GO] 2020―Apr―17 COVID-19 Research in Brief: 11 April to 17 April, 2020 Thiago Carvalho
317 [GO] 2020―Apr―17 Biomedical research: lessons from the last decade’s crisis and austerity-stricken small countries for the current COVID-19-related crisis George P. Chrousos, Alexios-Fotios A. Mentis, Efthimios Dardiotis
318 [GO] 2020―Apr―16 Caring for patients with cancer in the COVID-19 era Joris van de Haar, Louisa R. Hoes, Charlotte E. Coles, Kenneth Seamon, Stefan Fröhling, Dirk Jäger, et al. (+15)
319 [GO] 2020―Apr―16 How is biomedical research funding faring during the COVID-19 lockdown? Paul Webster
320 [GO] 2020―Apr―15 Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Xilong Deng, Jian Wang, Xinxin Hao, et al. (+17)
321 [GO] 2020―Apr―14 COVID-19 Research in Brief: 4 April to 10 April, 2020 Thiago Carvalho
322 [GO] 2020―Apr―14 Coping with COVID-19: scaling up virtual care to standard practice Esther Z. Barsom, Tim M. Feenstra, Willem A. Bemelman, Jaap H. Bonjer, Marlies P. Schijven
323 [GO] 2020―Apr―09 Lopinavir-ritonavir in severe COVID-19 Hannah Stower
324 [GO] 2020―Apr―09 Clinical and epidemiological characteristics of children with COVID-19 Hannah Stower
325 [GO] 2020―Apr―09 A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys Hagai Rossman, Ayya Keshet, Smadar Shilo, Amir Gavrieli, Tal Bauman, Ori Cohen, et al. (+5)
326 [GO] 2020―Apr―09 If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future Martin McKee, David Stuckler
327 [GO] 2020―Apr―09 Functionally assessing coronavirus entry Hannah Stower
328 [GO] 2020―Apr―09 Spread of SARS-CoV-2 Hannah Stower
329 [GO] 2020―Apr―09 Virological assessment of SARS-CoV-2 Hannah Stower
330 [GO] 2020―Apr―08 Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus Deepak Jakhar, Ishmeet Kaur
331 [GO] 2020―Apr―08 COVID-19 in humanitarian settings and lessons learned from past epidemics Ling San Lau, Goleen Samari, Rachel T. Moresky, Sara E. Casey, S. Patrick Kachur, Leslie F. Roberts, Monette Zard
332 [GO] 2020―Apr―03 COVID-19 Research in Brief: 28 March to 3 April, 2020 Thiago Carvalho
333 [GO] 2020―Apr―02 Safeguard research in the time of COVID-19
334 [GO] 2020―Mar―27 Digital technology and COVID-19 Daniel Shu Wei Ting, Lawrence Carin, Victor Dzau, Tien Y. Wong
335 [GO] 2020―Mar―27 On the responsible use of digital data to tackle the COVID-19 pandemic Marcello Ienca, Effy Vayena
336 [GO] 2020―Mar―27 COVID-19 Research in Brief: 20 March to 27 March, 2020 Thiago Carvalho
337 [GO] 2020―Mar―26 COVID-19: Biomedical research in a world under social-distancing measures Carrie Arnold
338 [GO] 2020―Mar―26 Combating COVID-19: health equity matters Zhicheng Wang, Kun Tang
339 [GO] 2020―Mar―19 Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, et al. (+3)
340 [GO] 2020―Mar―17 The proximal origin of SARS-CoV-2 Kristian G. Andersen, Andrew Rambaut, W. Ian Lipkin, Edward C. Holmes, Robert F. Garry
341 [GO] 2020―Mar―16 Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 Irani Thevarajan, Thi H. O. Nguyen, Marios Koutsakos, Julian Druce, Leon Caly, Carolien E. van de Sandt, et al. (+7)
342 [GO] 2020―Mar―13 Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Yi Xu, Xufang Li, Bing Zhu, Huiying Liang, Chunxiao Fang, Yu Gong, et al. (+10)
343 [GO] 2020―Mar―11 Nigeria responds to COVID-19; first case detected in sub-Saharan Africa Paul Adepoju
344 [GO] 2020―Mar―11 Lack of maternal-fetal SARS-CoV-2 transmission Hannah Stower
345 [GO] 2020―Mar―09 In the fight against the new coronavirus outbreak, we must also struggle with human bias Joana Gonçalves-Sá
346 [GO] 2020―Mar―05 Author Correction: China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response John Nkengasong
347 [GO] 2020―Feb―27 Emergence of a novel human coronavirus threatening human health Leo L. M. Poon, Malik Peiris
348 [GO] 2020―Feb―19 Four ways researchers are responding to the COVID-19 outbreak Amanda B. Keener
349 [GO] 2020―Feb―03 Communication, collaboration and cooperation can stop the 2019 coronavirus
350 [GO] 2020―Jan―27 China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response John Nkengasong
 [1] 

350 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.149 sec